Fernanda Ludolf

1.4k total citations
36 papers, 545 citations indexed

About

Fernanda Ludolf is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Organic Chemistry. According to data from OpenAlex, Fernanda Ludolf has authored 36 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Public Health, Environmental and Occupational Health, 24 papers in Epidemiology and 10 papers in Organic Chemistry. Recurrent topics in Fernanda Ludolf's work include Research on Leishmaniasis Studies (28 papers), Trypanosoma species research and implications (24 papers) and Parasites and Host Interactions (10 papers). Fernanda Ludolf is often cited by papers focused on Research on Leishmaniasis Studies (28 papers), Trypanosoma species research and implications (24 papers) and Parasites and Host Interactions (10 papers). Fernanda Ludolf collaborates with scholars based in Brazil, United Kingdom and Peru. Fernanda Ludolf's co-authors include Eduardo Antônio Ferraz Coelho, Daniela P. Lage, Mariana C. Duarte, Miguel Á. Chávez‐Fumagalli, Débora V.C. Mendonça, Bruno Mendes Roatt, Guilherme Oliveira, Daniel Menezes‐Souza, Carlos Alberto Pereira Tavares and D. Brent Weatherly and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Science Advances.

In The Last Decade

Fernanda Ludolf

35 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernanda Ludolf Brazil 17 327 227 145 125 92 36 545
Emile Barrias Brazil 15 324 1.0× 436 1.9× 124 0.9× 222 1.8× 108 1.2× 22 722
María Laura Chiribao Uruguay 9 200 0.6× 281 1.2× 100 0.7× 138 1.1× 45 0.5× 16 403
Andrew W. Pountain United Kingdom 11 724 2.2× 496 2.2× 111 0.8× 169 1.4× 182 2.0× 15 943
Alicia Moreno‐Sabater France 17 419 1.3× 320 1.4× 76 0.5× 146 1.2× 78 0.8× 37 917
Juliana Perrone Bezerra de Menezes Brazil 14 398 1.2× 305 1.3× 91 0.6× 146 1.2× 52 0.6× 25 532
Jacqueline Búa Argentina 18 556 1.7× 765 3.4× 201 1.4× 268 2.1× 120 1.3× 48 915
Adriana Parodi‐Talice Uruguay 15 527 1.6× 574 2.5× 145 1.0× 291 2.3× 117 1.3× 24 822
Mahshid Mostafavi Iran 15 319 1.0× 127 0.6× 47 0.3× 24 0.2× 52 0.6× 31 411
Rory Cristiane Fortes de Brito Brazil 11 452 1.4× 264 1.2× 97 0.7× 112 0.9× 71 0.8× 30 542
Edoardo Torres‐Guerrero Mexico 5 635 1.9× 422 1.9× 122 0.8× 106 0.8× 115 1.3× 11 817

Countries citing papers authored by Fernanda Ludolf

Since Specialization
Citations

This map shows the geographic impact of Fernanda Ludolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernanda Ludolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernanda Ludolf more than expected).

Fields of papers citing papers by Fernanda Ludolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernanda Ludolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernanda Ludolf. The network helps show where Fernanda Ludolf may publish in the future.

Co-authorship network of co-authors of Fernanda Ludolf

This figure shows the co-authorship network connecting the top 25 collaborators of Fernanda Ludolf. A scholar is included among the top collaborators of Fernanda Ludolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernanda Ludolf. Fernanda Ludolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramos, Fernanda F., Fernanda Ludolf, Guilherme de Paula Costa, et al.. (2024). Immunotherapy Combining Mimotopes Selected by Phage Display Plus Amphotericin B Is Effective for Treatment Against Visceral Leishmaniasis. Parasite Immunology. 46(5). e13037–e13037. 1 indexed citations
2.
Lage, Daniela P., Vívian T. Martins, Camila S. Freitas, et al.. (2023). The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice. Acta Tropica. 246. 106986–106986. 2 indexed citations
3.
Freitas, Camila S., Vívian T. Martins, Amanda S. Machado, et al.. (2023). Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis. Biology. 12(6). 851–851. 5 indexed citations
4.
Ludolf, Fernanda, Fernanda F. Ramos, & Eduardo Antônio Ferraz Coelho. (2023). Immunoproteomics and phage display in the context of leishmaniasis complexity. Frontiers in Immunology. 14. 1112894–1112894. 3 indexed citations
5.
Freitas, Camila S., Daniela P. Lage, Luciana Maria Ribeiro Antinarelli, et al.. (2023). In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis. Experimental Parasitology. 251. 108555–108555. 3 indexed citations
6.
Machado, Amanda S., Daniela P. Lage, Camila S. Freitas, et al.. (2022). Leishmania   LiHyC protein is immunogenic and induces protection against visceral leishmaniasis. Parasite Immunology. 44(8). e12921–e12921. 2 indexed citations
7.
Machado, Amanda S., Daniela P. Lage, Camila S. Freitas, et al.. (2022). A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum. Acta Tropica. 230. 106412–106412. 3 indexed citations
8.
Oliveira‐da‐Silva, João A., Grasiele S.V. Tavares, Débora V.C. Mendonça, et al.. (2020). Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis. Experimental Parasitology. 221. 108059–108059. 16 indexed citations
9.
Mendonça, Débora V.C., Grasiele S.V. Tavares, Daniela P. Lage, et al.. (2019). Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis. Experimental Parasitology. 199. 30–37. 13 indexed citations
10.
Antinarelli, Luciana Maria Ribeiro, Débora V.C. Mendonça, Daniela P. Lage, et al.. (2019). A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis. Parasitology International. 73. 101966–101966. 9 indexed citations
11.
Martins, Vívian T., Fernanda Ludolf, Fernanda F. Ramos, et al.. (2019). Immunodiagnosis of human and canine visceral leishmaniasis using recombinant Leishmania infantum Prohibitin protein and a synthetic peptide containing its conformational B-cell epitope. Journal of Immunological Methods. 474. 112641–112641. 11 indexed citations
12.
Mendonça, Débora V.C., Grasiele S.V. Tavares, Daniela P. Lage, et al.. (2018). In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection. Biomedicine & Pharmacotherapy. 109. 779–787. 20 indexed citations
13.
Ribeiro, Patrícia A.F., Daniel Dias, Daniela P. Lage, et al.. (2018). A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis. Cytokine. 111. 131–139. 16 indexed citations
14.
Chávez‐Fumagalli, Miguel Á., Daniela P. Lage, Grasiele S.V. Tavares, et al.. (2018). In silico Leishmania proteome mining applied to identify drug target potential to be used to treat against visceral and tegumentary leishmaniasis. Journal of Molecular Graphics and Modelling. 87. 89–97. 10 indexed citations
15.
Ribeiro, Patrícia A.F., Daniel Dias, Daniela P. Lage, et al.. (2018). Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection. Molecular Immunology. 106. 108–118. 16 indexed citations
16.
Tavares, Grasiele S.V., Débora V.C. Mendonça, Daniela P. Lage, et al.. (2018). A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection. Parasitology International. 68(1). 63–72. 19 indexed citations
17.
Duarte, Mariana C., Daniela P. Lage, Vívian T. Martins, et al.. (2016). A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection. Immunobiology. 222(2). 251–260. 16 indexed citations
18.
Ludolf, Fernanda, Daniel G. W. Alanine, Xiaowei Wang, et al.. (2014). Use of Humanised Rat Basophilic Leukaemia Cell Line RS-ATL8 for the Assessment of Allergenicity of Schistosoma mansoni Proteins. PLoS neglected tropical diseases. 8(9). e3124–e3124. 21 indexed citations
19.
Ludolf, Fernanda, Rodrigo Corrêa‐Oliveira, Andréa Gazzinelli, et al.. (2014). Serological Screening of the Schistosoma mansoni Adult Worm Proteome. PLoS neglected tropical diseases. 8(3). e2745–e2745. 31 indexed citations
20.
Ludolf, Fernanda, Diana Bahia, Luiza F Andrade, et al.. (2007). Molecular analysis of SmFes, a tyrosine kinase of Schistosoma mansoni orthologous to the members of the Fes/Fps/Fer family. Biochemical and Biophysical Research Communications. 360(1). 163–172. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emile Barrias Breakdown of academic impact, for papers by María Laura Chiribao Breakdown of academic impact, for papers by Andrew W. Pountain Breakdown of academic impact, for papers by Alicia Moreno‐Sabater Breakdown of academic impact, for papers by Juliana Perrone Bezerra de Menezes Breakdown of academic impact, for papers by Jacqueline Búa Breakdown of academic impact, for papers by Adriana Parodi‐Talice Breakdown of academic impact, for papers by Mahshid Mostafavi Breakdown of academic impact, for papers by Rory Cristiane Fortes de Brito Breakdown of academic impact, for papers by Edoardo Torres‐Guerrero
Rankless by CCL
2026